Listen to our leaders
Ashu Tandon
Naveen Kumar Annam
Vaibhav Sihorkar
Kumaran Moghily Reddy
At Aragen, we offer the full spectrum of drug development services designed to meet your specific requirements from early-stage development to commercialization. Our expertise spans from non-GMP/GMP-grade key starting materials (KSMs) to advanced intermediates and active pharmaceutical ingredients (APIs), available in quantities ranging from kilo laboratory to plant scale.
Our experienced team adeptly navigates potential challenges in both early and late-stage development. This proactive approach ensures smooth technology transfer from preclinical supply to commercial manufacturing, significantly reducing development timelines.
We offer comprehensive development services, including:
Early-Stage Development: Rapid, efficient transition from discovery to development, ensuring a smooth progression.
Process Development: Expertise in process optimization, ensuring scalability and cost-effectiveness.
Analytical Development: Robust analytical methodologies to support product development and regulatory submissions.
Formulation Development: Innovative solutions for both small molecules and biologics, including solid oral formulations and injectables.
Technology Transfer: Seamless transfer of processes from development to manufacturing.
Meet us at Hall No. 7, stand No. C130. Walk-ins are welcome, but if you'd prefer to schedule a meeting, please fill in your details to secure a slot.
We look forward to seeing you at the show and discussing how we can support your journey from development to market!
Global CRDMO with industry-leading capabilities
- Concept to Commercial
- Collaborative approach
- ~25-year track record serving the life sciences industry
- 3,800+ scientists and 450+ PhDs
- 400+ clients in US, Europe, and JAPAC
- 7/10 big pharma and 100+ biotechs
- >95% of FY23 revenue from innovator clients
- Pharmaceutical & Biotech, Animal Health, Agrochemical, Nutrition, Specialty & Performance Chemicals
Scalable platform with world-class infrastructure
- 5 campuses in India + 2 campuses in US
- Alternative sites for expansion, flexibility and risk-mitigation
- Accredited by USFDA, EQDM and PMDA
- Future-forward investment strategy
- Small molecule and biologics solutions
- Integrated platform to follow the molecule
- Track record in NCEs
- Biologics advantage – Gene to GMP
Aragen’s leadership presence at CPHI
Manni Kantipudi
Chief Executive Officer
Subodh Deshmukh
Chief Executive Officer- Biologics
President Development
Ashu Tandon
Chief Commercial Officer
D Vijaya Bharathi, PhD
VP & Head, Analytical Solutions
Naveen Kumar Annam
VP & Head, Custom Manufacturing Solutions
Vaibhav Sihorkar
VP & Head
Formulations Solutions
Amar Karandikar
SVP & Head, Business Development, NA
Srinivas Reddy Mamidi
SVP & Global Head, Business Development, Key Accounts & Europe